Gentian Diagnostics: Annual report 2025

20. Mar 2026 | 1 min read

Moss, 20 March 2026

Gentian Diagnostics has today published its annual report for 2025. The annual report and the ESEF file is attached to this stock exchange notice and is also available on www.gentian.com. 

IR contact: 
Njaal Kind, CFO 
njaal.kind@gentian.no 
+47 919 06 525 (mobile)

The report can be found here: Annual report 2025


This information is subject to disclosure requirements pursuant to §5-12 of the Norwegian Securities Trading Act

You may also read


May 06, 2026 - Ole Sørlie

Gentian Diagnostics: First quarter 2026 report

Moss, 6 May 2026 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic tests,..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics ASA terminates NT-proBNP assay development

Moss, 6 May 2026 Following a comprehensive review of performance data and market dynamics, Gentian..

May 06, 2026 - Ole Sørlie

Gentian Diagnostics: Ex dividend NOK 0.60 today

Moss, 6 May 2026 The shares in Gentian Diagnostics ASA will be traded ex dividend NOK 0.60 as of today. The..